Results 161 to 170 of about 29,891 (282)

Fasting Ketone Bodies and Incident Type 2 Diabetes in the General Population. [PDF]

Diabetes, 2023
Szili-Torok T, de Borst MH, Garcia E, Gansevoort RT, Dullaart RPF, Connelly MA, Bakker SJL, Tietge UJF.   +7 more
europepmc   +1 more source

Studies on Serum Ketone Bodies in Patients with Hyperthyroidism

, 1988
Kiyoshi Kunihiro, Shiro Noguchi, Nobuo Murakami, Ryoji Kato, Yasuhiro Oribe, Ryosaburo Takaki   +5 more
openalex   +2 more sources

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Ketone Bodies in the Regulation of Myocardial Perfusion in Cardiovascular Disease: Metabolic and Vasodilatory Effects. [PDF]

Int J Mol Sci
Aromiwura AA, Gouwens KR, Nguyen DC, Sztukowska M, Didelot L, Kalra DK.   +5 more
europepmc   +1 more source

Ketone bodies: A double-edged sword for mammalian life span. [PDF]

Aging Cell, 2023
Tomita I, Tsuruta H, Yasuda-Yamahara M, Yamahara K, Kuwagata S, Tanaka-Sasaki Y, Chin-Kanasaki M, Fujita Y, Nishi E, Katagiri H, Maegawa H, Kume S.   +11 more
europepmc   +1 more source

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li, Max Homilius, Erin Achilles, Laura K. Massey, Victoria Convey, Åsa Ohlsson, Ingrid Ljungvall, Jens Häggström, Brittany Vester Boler, Pascal Steiner, Sharlene Day, Calum A. MacRae, Mark A. Oyama   +12 more
wiley   +1 more source

Endogenous Ketone Bodies Are Associated with Metabolic Vulnerability and Disability in Multiple Sclerosis. [PDF]

Nutrients
Wicks TR, Shalaurova I, Wolska A, Browne RW, Weinstock-Guttman B, Zivadinov R, Remaley AT, Otvos JD, Ramanathan M.   +8 more
europepmc   +1 more source

Circulating ketone bodies and cardiovascular outcomes: the MESA study. [PDF]

Eur Heart J, 2023
Shemesh E, Chevli PA, Islam T, German CA, Otvos J, Yeboah J, Rodriguez F, deFilippi C, Lima JAC, Blaha M, Pandey A, Vaduganathan M, Shapiro MD.   +12 more
europepmc   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

Epilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Circulating FGF21 and Ketone Bodies Modify the Risk of MASLD and Mortality: Insights from the PREVEND Cohort Study. [PDF]

Int J Mol Sci
Chvatal-Medina M, Li Y, Dam WA, Connelly MA, Moshage H, Bakker SJL, Dullaart RPF, Post A.   +7 more
europepmc   +1 more source